Safety and Efficacy of Oral BAY 85-8501 in Patients with inflammation of the tubes in the lungs

Update Il y a 4 ans
Reference: EUCTR2012-004491-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the safety and tolerability of 28 day oral administration of BAY 85-8501 versus placebo in subjects with non-CF Bronchiectasis (BE)


Inclusion criteria

  • Non-Cystic Fibrosis Bronchiectasis